Joel Glover - Physiology
iPS cell-based in vitro human disease modeling at the Norwegian Core Facility for Human Pluripotent Stem Cells
Published May 25, 2020 8:52 AM
- Last modified June 6, 2020 9:18 PM
iPS cell-based in vitro human disease modeling at the Norwegian Core Facility for Human Pluripotent Stem Cells